Nakatani Y - Search Results

1

Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.

Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, Umayahara Y, Kosugi K, Kaneto H, Yamasaki Y, Hori M. Yoshiuchi K, et al. Among authors: nakatani y. Endocr J. 2008 Jul;55(3):503-7. doi: 10.1507/endocrj.k07e-089. Epub 2008 Apr 30. Endocr J. 2008. PMID: 18445997 Free article.

2

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y. Katakami N, et al. Among authors: nakatani y. Diabetes Care. 2005 Nov;28(11):2716-21. doi: 10.2337/diacare.28.11.2716. Diabetes Care. 2005. PMID: 16249545

3

Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice.

Yoshiuchi K, Kaneto H, Matsuoka TA, Kasami R, Kohno K, Iwawaki T, Nakatani Y, Yamasaki Y, Shimomura I, Matsuhisa M. Yoshiuchi K, et al. Among authors: nakatani y. Endocr J. 2009;56(9):1103-11. doi: 10.1507/endocrj.k09e-140. Epub 2009 Sep 29. Endocr J. 2009. PMID: 19789420 Free article.

4

Modulation of the JNK pathway in liver affects insulin resistance status.

Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y, Hori M. Nakatani Y, et al. J Biol Chem. 2004 Oct 29;279(44):45803-9. doi: 10.1074/jbc.M406963200. Epub 2004 Aug 24. J Biol Chem. 2004. PMID: 15331609 Free article.

5

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.

Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y, Hori M. Kaneto H, et al. Among authors: nakatani y. Nat Med. 2004 Oct;10(10):1128-32. doi: 10.1038/nm1111. Epub 2004 Sep 26. Nat Med. 2004. PMID: 15448687

6

Involvement of endoplasmic reticulum stress in insulin resistance and diabetes.

Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, Ozawa K, Ogawa S, Hori M, Yamasaki Y, Matsuhisa M. Nakatani Y, et al. J Biol Chem. 2005 Jan 7;280(1):847-51. doi: 10.1074/jbc.M411860200. Epub 2004 Oct 27. J Biol Chem. 2005. PMID: 15509553 Free article.

7

Oxidative stress and the JNK pathway as a potential therapeutic target for diabetes.

Kaneto H, Kawamori D, Nakatani Y, Gorogawa S, Matsuoka TA. Kaneto H, et al. Among authors: nakatani y. Drug News Perspect. 2004 Sep;17(7):447-53. doi: 10.1358/dnp.2004.17.7.863704. Drug News Perspect. 2004. PMID: 15514704 Review.

8

Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.

Nakahara I, Matsuhisa M, Shiba Y, Kuroda A, Nakatani Y, Hatazaki M, Kajimoto Y, Kubota M, Yamasaki Y, Hori M. Nakahara I, et al. Among authors: nakatani y. Diabetes Res Clin Pract. 2004 Nov;66(2):109-18. doi: 10.1016/j.diabres.2004.02.016. Diabetes Res Clin Pract. 2004. PMID: 15533577

9

A crucial role of MafA as a novel therapeutic target for diabetes.

Kaneto H, Matsuoka TA, Nakatani Y, Miyatsuka T, Matsuhisa M, Hori M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. J Biol Chem. 2005 Apr 15;280(15):15047-52. doi: 10.1074/jbc.M412013200. Epub 2005 Jan 20. J Biol Chem. 2005. PMID: 15664997 Free article.

10

Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y. Kaneto H, et al. Among authors: nakatani y. J Mol Med (Berl). 2005 Jun;83(6):429-39. doi: 10.1007/s00109-005-0640-x. Epub 2005 Mar 10. J Mol Med (Berl). 2005. PMID: 15759102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,143 results

Search Page